Compumedics Pty Ltd.

Abbotsford, Australia

Compumedics Pty Ltd.

Abbotsford, Australia
SEARCH FILTERS
Time filter
Source Type

Wiseguyreports.Com Adds “Sleep Apnea Diagnostic and Therapeutic Devices -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database This report studies sales (consumption) of Sleep Apnea Diagnostic and Therapeutic Devices in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Sleep Apnea Diagnostic and Therapeutic Devices in these regions, from 2012 to 2022 (forecast), like Split by product Types, with Sales, Revenue, Price and Gross Margin, market share and growth rate of each type, can be divided into Sleep Apnea Diagnostic Device Sleep Apnea Therapeutic Devices Mandibular Advancement Devices Tongue Retaining Devices Others Split by applications, this report focuses on sales, market share and growth rate of Sleep Apnea Diagnostic and Therapeutic Devices in each application, can be divided into Household Hospital and Clinics Recovery Center Others Global Sleep Apnea Diagnostic and Therapeutic Devices Sales Market Report 2017 1 Sleep Apnea Diagnostic and Therapeutic Devices Overview 1.1 Product Overview and Scope of Sleep Apnea Diagnostic and Therapeutic Devices 1.2 Classification of Sleep Apnea Diagnostic and Therapeutic Devices 1.2.1 Sleep Apnea Diagnostic Device 1.2.2 Sleep Apnea Therapeutic Devices 1.2.2.1 Mandibular Advancement Devices 1.2.2.2 Tongue Retaining Devices 1.2.3 Others 1.3 Applications of Sleep Apnea Diagnostic and Therapeutic Devices 1.3.1 Household 1.3.2 Hospital and Clinics 1.3.3 Recovery Center 1.3.4 Others 1.4 Sleep Apnea Diagnostic and Therapeutic Devices Market by Regions 1.4.1 USA Status and Prospect (2012-2022) 1.4.2 China Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 Japan Status and Prospect (2012-2022) 1.4.5 India Status and Prospect (2012-2022) 1.4.6 Southeast Asia Status and Prospect (2012-2022) 1.5 Global Market Size (Value and Volume) of Sleep Apnea Diagnostic and Therapeutic Devices (2012-2022) 1.5.1 Global Sleep Apnea Diagnostic and Therapeutic Devices Sales and Growth Rate (2012-2022) 1.5.2 Global Sleep Apnea Diagnostic and Therapeutic Devices Revenue and Growth Rate (2012-2022) 9 Global Sleep Apnea Diagnostic and Therapeutic Devices Manufacturers Analysis 9.1 Philips 9.1.1 Company Basic Information, Manufacturing Base and Competitors 9.1.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.1.2.1 Type one 9.1.2.2 Type two 9.1.3 Philips Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.1.4 Main Business/Business Overview 9.2 WEINMANN Geraete 9.2.1 Company Basic Information, Manufacturing Base and Competitors 9.2.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.2.2.1 Type one 9.2.2.2 Type two 9.2.3 WEINMANN Geraete Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.2.4 Main Business/Business Overview 9.3 MALLINCKRODT 9.3.1 Company Basic Information, Manufacturing Base and Competitors 9.3.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.3.2.1 Type one 9.3.2.2 Type two 9.3.3 MALLINCKRODT Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.3.4 Main Business/Business Overview 9.4 ResMed Limited 9.4.1 Company Basic Information, Manufacturing Base and Competitors 9.4.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.4.2.1 Type one 9.4.2.2 Type two 9.4.3 ResMed Limited Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.4.4 Main Business/Business Overview 9.5 Compumedics Limited 9.5.1 Company Basic Information, Manufacturing Base and Competitors 9.5.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.5.2.1 Type one 9.5.2.2 Type two 9.5.3 Compumedics Limited Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.5.4 Main Business/Business Overview 9.6 Watermark Medical 9.6.1 Company Basic Information, Manufacturing Base and Competitors 9.6.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.6.2.1 Type one 9.6.2.2 Type two 9.6.3 Watermark Medical Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.6.4 Main Business/Business Overview 9.7 Embla Systems 9.7.1 Company Basic Information, Manufacturing Base and Competitors 9.7.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.7.2.1 Type one 9.7.2.2 Type two 9.7.3 Embla Systems Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.7.4 Main Business/Business Overview 9.8 MRA Medical Ltd (Spiro Medical) 9.8.1 Company Basic Information, Manufacturing Base and Competitors 9.8.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.8.2.1 Type one 9.8.2.2 Type two 9.8.3 Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin MRA Medical Ltd (Spiro Medical) (2012-2017) 9.9 WideMed 9.9.1 Company Basic Information, Manufacturing Base and Competitors 9.9.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.9.2.1 Type one 9.9.2.2 Type two 9.9.3 WideMed Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.9.4 Main Business/Business Overview 9.10 CADWELL LABORATORIES 9.10.1 Company Basic Information, Manufacturing Base and Competitors 9.10.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.10.2.1 Type one 9.10.2.2 Type two 9.10.3 CADWELL LABORATORIES Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 10.8.4 Main Business/Business Overview 9.11 SOMNOmedics GmbH 9.12 BMC Medical 9.13 Curative Medical 9.14 SnoreDoc 9.15 Contec Medical 9.16 Glidewell 9.17 Laboratories 9.18 SomnMed 9.19 Vital Sleep For more information, please visit https://www.wiseguyreports.com/sample-request/1004461-global-sleep-apnea-diagnostic-and-therapeutic-devices-sales-market-report-2017


Receive press releases from IQ4I Research & Consultancy Pvt. Ltd.: By Email IQ4I Research & Consultancy Published a New Report on "Brain Monitoring Devices Global Market – Forecast to 2023" Brain monitoring devices aid in understand the activity of brain and explore structure and functions. Increasing incidence and prevalence neurological diseases, rising awareness, technological advancements/innovations are driving the market growth. Boston, MA, April 25, 2017 --( Brain monitoring devices market is growing at a steady rate, as estimated by IQ4I Research the market is expected to reach $10.01billion by 2023. The major factors driving the brain monitoring device market includes growing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative disorders, growing healthcare spending and technological advancements/innovations offering wider scope of applications for brain monitoring. However, some of the factors like shortage of trained professionals, high cost of complex devices, stringent regulations and unfavorable reimbursement policies may hinder the growth of global brain monitoring device market. The brain monitoring devices global market is segmented based on their products, applications, end users and geography. Among products, sleep monitoring devices holds the largest market share because of the advancements in portable sleep devices technologies and growing incidence of obstructive sleep apnea. Sleep monitoring devices is expected to grow at the single digit mid-CAGR. The global brain monitoring devices application segment is classified into neurodegenerative disorders, brain tumor, psychiatric disorders, sleep disorders and other applications. Neurodegenerative diseases are characterized by progressive loss of neurons in the central nervous system and Epilepsy, Parkinson's disease (PD), Huntington’s disease falls under this category. In 2016, the market was estimated to be dominated by neurodegenerative disorders. The large share of this segment can be attributed to the growing incidence of Traumatic Brain Injuries (TBIs) globally owing to various factors like, increasing occurrence of falls, blunt trauma and motor vehicle crashes among other causes of TBIs and along with the increasing aging population. Geographically, the bran monitoring devices market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America region held the largest market share within that United States accounted for the largest share this growth is driven due to its high acceptance of advanced technologies and sophisticated universal treatment facilities. Asia- Pacific region is the fastest growing region due to its increase in healthcare spending and advancements in healthcare facilities, the easy access to advanced healthcare technology. The global brain monitoring devices market is fragmented where key players like GE Healthcare (U.S.), Philips N.V. (Netherland), Siemens Healthineers (Germany), Medtronic (Ireland) and Natus Medical Inc. (U.S.) holding a major share in 2016. The protection of intellectual property rights plays a very important role as a long term strategy for survival of the company and to maintain a competitive advantage. According to IQ4I Analysis, Advanced Brain Monitoring filed the largest number of PCT applications followed by Siemens Healthineers and Philips N.V. at World Intellectual Property Organization (WIPO). Some of the prominent players in brain monitoring device market include Advanced Brain Monitoring (U.S.), Cadwell Laboratories (U.S.), CAS Medicals Inc. (U.S), Compumedics Limited (Australia), Electrical Geodesics Incorporated (U.S.), Elekta AB (Sweden), GE Healthcare (U.S.), Integra Lifesciences (U.S.), Koninklijke Philips N.V. (Netherland), Masimo corporation (U.S.), Medtronic (Ireland), Natus Medical Inc.(U.S.), Nihon Kohden Corporation (Japan) and Siemens Healthineers (Germany). Boston, MA, April 25, 2017 --( PR.com )-- Brain monitoring devices are used to monitor and diagnose the neurological conditions by exploring the structure and functions of the brain in patients. These devices provide the information of the brain and greater understanding of neurological problems, with possible new treatments. Among brain monitoring devices CT and MRI are the conventional devices which are being used for the structural diagnosis of the brain like tumour, head injury etc., whereas EEG, MEG, TCD, oximeters and ICP monitors are the recent techniques used for the functional imaging of the brain. EEG measures the electrical activity generated by the various cortical layers of the brain whereas, MEG capture the magnetic fields generated by neural activity within the brain. Similarly, TCD measures the velocity of the blood flow through the brain’s blood vessels, oximeters are used to measure the regional cerebral oxygen saturation with in the brain and ICP monitors monitor the intracranial pressure within the skull while treating severe traumatic brain injury in patients. In addition to all these devices, sleep monitoring devices which occupies major share in the brain monitoring devices global market, are being used to understand the person’s sleep physiology and track sleep with the aim of finding patterns and correlations with person’s behaviours.Brain monitoring devices market is growing at a steady rate, as estimated by IQ4I Research the market is expected to reach $10.01billion by 2023. The major factors driving the brain monitoring device market includes growing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative disorders, growing healthcare spending and technological advancements/innovations offering wider scope of applications for brain monitoring. However, some of the factors like shortage of trained professionals, high cost of complex devices, stringent regulations and unfavorable reimbursement policies may hinder the growth of global brain monitoring device market.The brain monitoring devices global market is segmented based on their products, applications, end users and geography. Among products, sleep monitoring devices holds the largest market share because of the advancements in portable sleep devices technologies and growing incidence of obstructive sleep apnea. Sleep monitoring devices is expected to grow at the single digit mid-CAGR.The global brain monitoring devices application segment is classified into neurodegenerative disorders, brain tumor, psychiatric disorders, sleep disorders and other applications. Neurodegenerative diseases are characterized by progressive loss of neurons in the central nervous system and Epilepsy, Parkinson's disease (PD), Huntington’s disease falls under this category. In 2016, the market was estimated to be dominated by neurodegenerative disorders. The large share of this segment can be attributed to the growing incidence of Traumatic Brain Injuries (TBIs) globally owing to various factors like, increasing occurrence of falls, blunt trauma and motor vehicle crashes among other causes of TBIs and along with the increasing aging population.Geographically, the bran monitoring devices market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America region held the largest market share within that United States accounted for the largest share this growth is driven due to its high acceptance of advanced technologies and sophisticated universal treatment facilities. Asia- Pacific region is the fastest growing region due to its increase in healthcare spending and advancements in healthcare facilities, the easy access to advanced healthcare technology.The global brain monitoring devices market is fragmented where key players like GE Healthcare (U.S.), Philips N.V. (Netherland), Siemens Healthineers (Germany), Medtronic (Ireland) and Natus Medical Inc. (U.S.) holding a major share in 2016. The protection of intellectual property rights plays a very important role as a long term strategy for survival of the company and to maintain a competitive advantage. According to IQ4I Analysis, Advanced Brain Monitoring filed the largest number of PCT applications followed by Siemens Healthineers and Philips N.V. at World Intellectual Property Organization (WIPO).Some of the prominent players in brain monitoring device market include Advanced Brain Monitoring (U.S.), Cadwell Laboratories (U.S.), CAS Medicals Inc. (U.S), Compumedics Limited (Australia), Electrical Geodesics Incorporated (U.S.), Elekta AB (Sweden), GE Healthcare (U.S.), Integra Lifesciences (U.S.), Koninklijke Philips N.V. (Netherland), Masimo corporation (U.S.), Medtronic (Ireland), Natus Medical Inc.(U.S.), Nihon Kohden Corporation (Japan) and Siemens Healthineers (Germany). Click here to view the list of recent Press Releases from IQ4I Research & Consultancy Pvt. Ltd.


News Article | May 8, 2017
Site: www.prlog.org

-- Global brain monitoring market is expected to reach USD 2.0 billion by 2024 from USD 1.2 billion in 2016, at a CAGR of 7.1% in the forecast period 2017 to 2024.The global radiotherapy market is segmented based on therapy, product, application and geography.·         EEG·         TCD·         MEG·         MRI·         CT·         PET·         EMG·         Internal beam radiotherapy·         Systemic radiation therapy·         Traumatic Brain Injury (TBI)·         Headache, dementia·         Epilepsy·         ParkinsonBased on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world.·         Nihon Kohden Corporation·         Philips Healthcare, Metronic PLC·         GE Healthcare, Siemens Healthcare·         Natus Medical Incorporated, Compumedics Limited·         Electrical Geodesics, Inc. CAS Medical Systems Inc·         Advanced Brain Monitoring·         B. Braun Medical, Becton·         Dickinson & Company·         DePuySynthes Companies·         Cadwell Industries, Inc·         Masimo Corporation·         Elekta AB (pub)·         Integra LifeSciences Corporation·         Rimed Inc.·         Yokogawa Electric Corporation·         EMOTIV Inc.and Neural AnalyticsReport Access: http://databridgemarketresearch.com/ reports/global- radiot... Data Bridge Market Research4th Floor, Mega Center,Magarpatta City, Pune – 411028Tel: +1-888-387-2818Email: Sales@databridgemarketresearch.comVisit Data Bridge Blog@ http://databridgemarketresearch.com/blog/LinkedIn: https://www.linkedin.com/company/data-bridge-market-research


News Article | May 8, 2017
Site: www.prnewswire.com

·         Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. ·         Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. ·         The global sleep aids market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023. ·         The global sleep aids market is segmented based on product, sleep disorder, and geography. ·         The market growth is attributed to the surge in prevalence of sleep disorders, rise in geriatric and obese population, and change in lifestyle. Sleep Aids Market by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) and Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders) - Global Opportunity Analysis and Industry Forecast, 2017-2023 Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. Sleep aids help to improve the quality of sleep by reducing the time required to fall asleep and increasing the duration of quality sleep. The global sleep aids market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023. The global sleep aids market is segmented based on product, sleep disorder, and geography. Based on product, it is categorized into mattress & pillows, sleep laboratories, medications, and sleep apnea devices. The medications segment is further divided into prescription-based drugs, over-the-counter (OTC) drugs, and herbal drugs. Based on sleep disorder, it is classified into insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleep walking, and other sleep disorder. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The market growth is attributed to the surge in prevalence of sleep disorders, rise in geriatric and obese population, and change in lifestyle. The surge in disposable income; increase in awareness about sleep disorders; stressful work issues; enhanced intake of caffeine, tobacco, and alcohol; and technological advancements are expected to boost the sleep aids market growth. However, adverse effects of sleep aids medication in patient with sleep disorders, such as dizziness, diarrhea, constipation, daytime drowsiness; and expiration on sleep drugs patents are expected to hamper the market growth. KEY MARKET BENEFITS This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities. Market estimations provided are based on comprehensive analysis of the key developments in the industry. The global market is comprehensively analyzed with respect to product, sleep disorder, and geography. In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning. The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market. KEY PLAYERS PROFILED Koninklijke Philips N.V. Merck & Co. Sanofi DeVilbiss Healthcare LLC. Pfizer Inc. SleepMed Inc. Cadwell Laboratories Inc. Compumedics Limited Natus Medical Incorporated GlaxoSmithKline plc. Sleep Aids Market Key Segments BY PRODUCT Mattresses & Pillows Sleep Laboratories Medications Prescription-based drugs OTC drugs Herbal drugs Sleep Apnea Devices BY SLEEP DISORDER Insomnia Sleep Apnea Restless Legs Syndrome Narcolepsy Sleep Walking Other Sleep Disorders BY GEOGRAPHY North America U.S. Canada Mexico Europe Germany UK France Spain Rest of Europe Asia-Pacific Japan China Australia India Rest of Asia-Pacific LAMEA Brazil Turkey Republic of South Africa Saudi Arabia Read the full report: http://www.reportlinker.com/p04883729/Sleep-Aids-Market-Global-Opportunity-Analysis-and-Industry-Forecast.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sleep-aids-market-is-estimated-to-reach-79851-million-by-2022-300453104.html


Despite increasing unit sales, increased competitiveness within the total patient monitoring market has had a negative impact on market growth. The entry of low cost foreign competition has been especially disruptive. However, the long-term prospects remain positive as demand for quality patient monitoring solutions will enable unit sales growth to outpace pricing pressure. Philips Healthcare is the leading competitor in the Australian patient monitoring market. The company competes in the multi-parameter vital sign monitoring market, wireless telemetry, pulse oximetry and fetal/neonatal monitoring markets. Their IntelliVue™ and SureSigns™ product lines range from low to high-acuity and have flexible product designs ranging from extremely compact to portable bedside units. GE Healthcare is the second leading competitor in the Australian patient monitoring market. GE offers an extensive product line that not only includes a range of low- to high-acuity monitoring devices, but also telemetry devices and networking solutions. Their product lines include the CARESCAPE™ B series and new B40™ patient monitors which can feed into the CARESCAPE™ central stations and mobile viewers to access patient information. Additional competitors in the Australia patient monitoring market include Dräger Medical, Medtronic, Mindray, Nihon Kohden, Natus Medical, Compumedics, Welch Allyn, Spacelabs Healthcare, Nonin and Smiths Medical among others. More on the patient monitoring device market in Australia can be found in a series of reports published by iData Research entitled the Australia Market Report Suite for Patient Monitoring Equipment. The suite covers reports on the following markets: multi-parameter vital signs monitoring, wireless ambulatory telemetry monitoring, telehealth, electromyogram monitoring, electroencephalogram monitoring, fetal and neonatal monitoring, pulse oximetry and blood pressure monitoring devices. The iData report series on patient monitoring devices covers the U.S., China, Australia, India, Japan, South Korea and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players' success strategies in each market and segment. To find out more about patient monitoring device market data, register online or email us at info@idataresearch.net for an Australia Market Report Suite for Patient Monitoring Equipment brochure and synopsis. iData Research (www.idataresearch.com) is an international market consulting research firm, dedicated to providing the best in business intelligence for the medical device industry. Our research empowers our clients by providing them with the necessary tools to achieve their goals and do it right the first time. iData covers research in: Ultrasound, X-Ray Imaging, Diagnostic Imaging, Oncology, Ophthalmics, Vascular Access, Laparoscopy, Urology, Gynecology, Endoscopy, Dental Operatory Equipment, Dental Material, Dental Lasers, Dental Prosthetics, Dental CAD/CAM, Dental Bone Graft Substitutes, Interventional Cardiology, Cardiac Surgery, Cardiac Rhythm Management, Electrophysiology, Operating Room Equipment, Surgical Microscopes, Robotics and Surgical Navigation, Spinal Implants and VCF, Spinal MIS, Orthopedic Soft Tissue Repair and Regeneration, Orthopedic Trauma, Large & Small Joints, Anesthesiology, Wound Management, Orthopedics and more. We have built a reputation and earned our clients' trust based on consistent and uniquely intelligent research that allows our customers to make confident decisions and impact their businesses. A combination of market expertise and over a decade of experience has resulted in a deep understanding of the medical device industry that has inspired innovation and propelled our clients to success. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/philips-and-ge-healthcare-lead-the-australia-patient-monitoring-equipment-market-due-to-the-adoption-of-less-invasive-more-accessible-patient-centric-device-configurations-300464048.html


— Factors such as increasing R&D investments by manufacturers to provide sophisticated brain monitoring devices, growing demand for efficient brain monitoring devices, rising incidence of neurological disorders and awareness about these disorders are some key factors driving the market growth. However, limitations of EEG devices are hindering the market growth. Amongst Products, 32-channel EEG segment acquired largest revenue during the forecast period. This segment would continue its dominance owing to technological advancements in the products and high acceptance by the healthcare professionals. Based on End User, hospital segment held the largest market share which can be attributed to the rising number of patients suffering with traumatic brain injuries, epilepsy, and other neurological disorders. North America dominated the Electroencephalography systems market which can be attributed to increasing occurrence of various sleep & neurodegenerative disorders and accessibility to insurance. Moreover, the existence of highly sophisticated healthcare infrastructure and strong distribution & sales network of leading vendors in this region drives the market growth. Some of the key players in the market include Compumedics Limited, BrainScope Company Inc, Natus Medical Inc., Medtronic, Noraxon U.S.A., Inc., Cadwell Laboratories Inc., Neurowave Systems Inc., EB Neuro S.P.A, Bio-Signal Group Corp., Elekta A.B., Nihon Kohden Corp., Electrical Geodesics Inc., Lifelines Neurodiagnostic Systems Inc., Jordan NeuroScience Inc., Neurosoft Ltd., CAS Medical Systems, Inc., Spiegelberg GmbH & Co., Yokogawa Electric, Integra LifeSciences Corporation, Grass technologies, Headsense Medical, Ltd, InnerSpace Neuro, Inc., DePuy Synthes, Covidien Medical devices, Nonin Medical Inc. and Rimed Ltd. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit: http://www.strategymrc.com For more information, please visit http://www.strategymrc.com/


— Growing demand for blood flow measurement devices in healthcare industry would be the major factor fostering the blood flow measurement devices market. Furthermore, rising prevalence of cardiovascular disease and diabetes coupled with increasing geriatric population, rising demand for minimally invasive surgeries, technological advancements in blood flow measurement devices, wide usage of these devices in various clinical applications, influx of VC funding, huge R&D investments by market players and increasing demand for technically advanced non-invasive devices are the factors fuelling market growth. However, stringent compliance requirements, high pricing of the devices, growing alternative methods to treat cardiovascular diseases and implementation of the Patient Protection and Affordable Healthcare Act, 2010 are limiting the market growth. Ultrasonic doppler segment is projected to witness substantial breakthrough advancements over the coming decade and is expected to provide lucrative avenues of growth. In Non-invasive applications, cardiovascular disease segment accounted for the major share whereas, Coronary Artery Bypass Grafting (CABG) devices dominated the invasive applications segment. North American region dominated the global blood flow measurement devices market with maximum revenue share due to rising prevalence of cardiovascular diseases & hypertension, increasing geriatric population, continues R&D activities for advanced products and favourable reimbursement scenario. Asia Pacific is expected to witness fastest growth on account of rapidly increasing demand for advanced healthcare technologies, increasing prevalence of cardiovascular diseases and diabetes in countries such as India and China. Some of the key players in global market include Ace Medicals, Adinstruments, ATYS Medical, Biomedix Inc, Biopac Systems Inc., Compumedics Limited, Cook Medical, Inc., Deltex Medical Group PLC, Getinge Group, Medistim ASA, Medtronics, Moor Instruments Ltd., Perimed AB, Sonotec Ultraschallsensorik Halle GmbH and Transonic Systems, Inc. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 6 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements About Stratistics MRC We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends. Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects. For more information, please visit: http://www.strategymrc.com For more information, please visit http://www.strategymrc.com/

Loading Compumedics Pty Ltd. collaborators
Loading Compumedics Pty Ltd. collaborators